SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015

Garcia-Campelo, R.; Bernabe, R.; Cobo, M.; Corral, J.; Coves Sarto, Juan; Domine, M.; Nadal, E.; Rodriguez-Abreu, D.; Vinolas, N.; Massuti, B.

doi:10.1007/s12094-015-1455-z

Identifier to cite or link to this item: http://hdl.handle.net/20.500.13003/16399

View

000368517900012.pdf (562.4Kb)

Identifiers

URI: http://hdl.handle.net/20.500.13003/16399

DOI: 10.1007/s12094-015-1455-z

ISSN: 1699-048X

eISSN: 1699-3055

WOS ID: 000368517900012

Scopus EID: 2-s2.0-84951274994

PMID: 26691657

Embase PUI: L607356748

Metrics

Export

External links

Publication date

2015-12

Document type

research article

Citation

Garcia-Campelo R, Bernabe R, Cobo M, Corral J, Coves J, Domine M, et al. SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015. Clin Transl Oncol. 2015 Dec;17(12):1020-9. Epub 2015 Dec 21.

Abstract

Lung cancer is the most common cancer worldwide as well as the leading cause of cancer related deaths as reported by Torre et al (CA Cancer J Clin 65: 87-108, 2015]. Non-small cell lung cancer (NSCLC) accounts for up to 85 % of all lung cancers. Multiple advances in the staging, diagnostic procedures, therapeutic options, as well as molecular knowledge have been achieved during the past years, although the overall outlook has not greatly changed for the majority of patients with the overall 5-year survival having marginally increased over the last decade from 15.7 to 17.4 % as reported by Howlader et al. (SEER Cancer Statistics Review 2015).